ATE238811T1 - Inhibitoren von farnesylprotein-transferase mit radiosensibilisierenden eigenschaften - Google Patents

Inhibitoren von farnesylprotein-transferase mit radiosensibilisierenden eigenschaften

Info

Publication number: ATE238811T1
Authority: AT; Austria
Prior art keywords: protein transferase; transferase inhibitors; farnesyl protein; radiosensitizing properties; radiosensitizing
Prior art date: 1998-07-06

Application number

AT99931229T

Other languages

English (en)

Inventor

Ginckel Robert Franciscus Van

Wim Joanna Floren

David William End

Walter Boudewijn Leopo Wouters

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-06

Filing date

1999-06-30

Publication date

2003-05-15

1999-06-30 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2003-05-15 Application granted granted Critical

2003-05-15 Publication of ATE238811T1 publication Critical patent/ATE238811T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Enzymes And Modification Thereof (AREA)

AT99931229T 1998-07-06 1999-06-30 Inhibitoren von farnesylprotein-transferase mit radiosensibilisierenden eigenschaften ATE238811T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP98202257		1998-07-06
EP98204330		1998-12-18
PCT/EP1999/004545 WO2000001411A1 (en)	1998-07-06	1999-06-30	Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties

Publications (1)

Publication Number	Publication Date
ATE238811T1 true ATE238811T1 (de)	2003-05-15

Family

ID=26150503

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99931229T ATE238811T1 (de)	1998-07-06	1999-06-30	Inhibitoren von farnesylprotein-transferase mit radiosensibilisierenden eigenschaften

Country Status (31)

Country	Link
US (1)	US6545020B1 (de)
EP (1)	EP1094839B1 (de)
JP (1)	JP4530537B2 (de)
KR (1)	KR100591603B1 (de)
CN (1)	CN1152716C (de)
AP (1)	AP1599A (de)
AT (1)	ATE238811T1 (de)
AU (1)	AU762423B2 (de)
BG (1)	BG64941B1 (de)
BR (1)	BR9911861A (de)
CA (1)	CA2336624C (de)
CZ (1)	CZ300968B6 (de)
DE (1)	DE69907461T2 (de)
DK (1)	DK1094839T3 (de)
EA (1)	EA003877B1 (de)
EE (1)	EE04582B1 (de)
ES (1)	ES2199579T3 (de)
HK (1)	HK1034451A1 (de)
HR (1)	HRP20000903A2 (de)
HU (1)	HU229076B1 (de)
ID (1)	ID26987A (de)
IL (2)	IL140721A0 (de)
MY (1)	MY126519A (de)
NO (1)	NO328178B1 (de)
PL (1)	PL193464B1 (de)
PT (1)	PT1094839E (de)
SI (1)	SI1094839T1 (de)
SK (1)	SK284723B6 (de)
TR (1)	TR200003879T2 (de)
TW (1)	TW586937B (de)
WO (1)	WO2000001411A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2336624C (en)	1998-07-06	2008-10-21	Janssen Pharmaceutica N.V.	Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties
HU229358B1 (en)	1998-07-06	2013-11-28	Janssen Pharmaceutica Nv	Farnesyl protein transferase inhibitors for treating arthropathies
EP1255537B1 (de) *	2000-02-04	2006-04-19	Janssen Pharmaceutica N.V.	Farnesyl protein transferase inhibitoren zur behandlung von brustkrebs
JO2361B1 (en)	2000-06-22	2006-12-12	جانسين فارماسيوتيكا ان. في	Enaniumer 1,2-anylated quinoline inhibitor for the transporter - farnesyl
EP1322636A1 (de)	2000-09-25	2003-07-02	Janssen Pharmaceutica N.V.	6-(substituierte phenyl)methyl)chinolin- und chinazolinderivate und deren verwendung als farneyl transferase inhibitoren
EP1322644A1 (de)	2000-09-25	2003-07-02	Janssen Pharmaceutica N.V.	6-heterocyclylmethyl chinolon derivate und deren verwendung als farnesyl transferase inhibitoren
JP4911866B2 (ja)	2000-09-25	2012-04-04	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	ファルネシルトランスフェラーゼ阻害剤としてのファルネシルトランスフェラーゼを阻害するキノリンおよびキナゾリン誘導体
WO2002024686A2 (en)	2000-09-25	2002-03-28	Janssen Pharmaceutica N.V.	Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
US7153958B2 (en)	2000-11-21	2006-12-26	Janssen Pharmaceutica N.V.	Farnesyl transferase inhibiting benzoheterocyclic derivatives
US7129356B2 (en)	2000-12-27	2006-10-31	Janssen Pharmaceutica N.V.	Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
WO2002051834A1 (en) *	2000-12-27	2002-07-04	Janssen Pharmaceutica N.V.	Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives
WO2003000266A1 (en)	2001-06-21	2003-01-03	Ariad Pharmaceuticals, Inc.	Novel quinolines and uses thereof
ES2323265T3 (es)	2001-12-19	2009-07-10	Janssen Pharmaceutica Nv	Derivados de quinolina condensados en 1,8 sustituidos con triazoles unidos por el carbono como inhibidores de la farnesil-transferasa.
DE60314381T2 (de)	2002-03-22	2008-02-21	Janssen Pharmaceutica N.V.	Benzylimidazolyl substituierte 2-chinolon und chinazolinon derivate zur verwendung als farnesyl transferase inhibitoren
ATE336496T1 (de)	2002-04-15	2006-09-15	Janssen Pharmaceutica Nv	Farnesyl transferase hemmende tricyclische quinazolinederivate substitutiert mit kohlenstoff-gebundenen imidazolen oder triazolen
AU2004295058B9 (en) *	2003-11-20	2011-06-30	Janssen Pharmaceutica N.V.	6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
US7517890B2 (en)	2003-11-20	2009-04-14	Children's Hospital Medical Center	GTPase inhibitors and methods of use
WO2005089518A2 (en) *	2004-03-18	2005-09-29	The Brigham And Women's Hospital, Inc.	Uch-l1 expression and cancer therapy
US20070293539A1 (en) *	2004-03-18	2007-12-20	Lansbury Peter T	Methods for the treatment of synucleinopathies
CA2559285A1 (en) *	2004-03-18	2005-09-29	Brigham And Women's Hospital, Inc.	Methods for the treatment of synucleinopathies
WO2005089496A2 (en) *	2004-03-18	2005-09-29	The Brigham And Women's Hospital, Inc.	Methods for the treatment of synucleinopathies
WO2005089504A2 (en) *	2004-03-18	2005-09-29	The Brigham And Women's Hospital, Inc.	Methods for the treatment of synucleinopathies
WO2005089515A2 (en) *	2004-03-18	2005-09-29	The Brigham And Women's Hospital, Inc.	Methods for the treatment of synucleinopathies
US20060194821A1 (en) *	2005-02-18	2006-08-31	The Brigham And Women's Hospital, Inc.	Compounds inhibiting the aggregation of superoxide dismutase-1
CA2617056A1 (en)	2005-07-29	2007-02-08	Children's Hospital Medical Center	Gtpase inhibitors and methods of use and crystal structure of rac-1 gtpase
AU2006331542A1 (en)	2005-12-23	2007-07-05	Link Medicine Corporation	Treatment of synucleinopathies
WO2008147788A1 (en) *	2007-05-23	2008-12-04	Allergan, Inc.	Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
US8232402B2 (en) *	2008-03-12	2012-07-31	Link Medicine Corporation	Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
ATE555384T1 (de)	2008-06-26	2012-05-15	Spherotec Gmbh	Verfahren zum testen der reaktion von zellen auf die einwirkung von therapeutika
MX2011005096A (es) *	2008-11-13	2011-11-18	Link Medicine Corp	Derivados de azaquinolinona y usos de los mismos.
US20100331363A1 (en) *	2008-11-13	2010-12-30	Link Medicine Corporation	Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
US20110060005A1 (en) *	2008-11-13	2011-03-10	Link Medicine Corporation	Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
WO2013166043A1 (en)	2012-05-02	2013-11-07	Children's Hospital Medical Center	Rejuvenation of precursor cells
PE20151203A1 (es)	2012-10-16	2015-08-31	Janssen Pharmaceutica Nv	MODULADORES DE QUINOLINILO UNIDOS A FENILO DE ROR-GAMMA-t
LT2909192T (lt)	2012-10-16	2017-07-10	Janssen Pharmaceutica Nv	Su metilenu sujungti rop-gama-t chinolinilo moduliatoriai
ES2619610T3 (es)	2012-10-16	2017-06-26	Janssen Pharmaceutica Nv	Moduladores de ROR-gamma-t de quinolinilo enlazado con heteroarilo
US9284308B2 (en)	2013-10-15	2016-03-15	Janssen Pharmaceutica Nv	Methylene linked quinolinyl modulators of RORγt
BR112016008215A2 (pt)	2013-10-15	2017-09-26	Janssen Pharmaceutica Nv	moduladores de quinolinila ligados por alquila de roryt
US9403816B2 (en)	2013-10-15	2016-08-02	Janssen Pharmaceutica Nv	Phenyl linked quinolinyl modulators of RORγt
US9328095B2 (en)	2013-10-15	2016-05-03	Janssen Pharmaceutica Nv	Heteroaryl linked quinolinyl modulators of RORgammat
US10555941B2 (en)	2013-10-15	2020-02-11	Janssen Pharmaceutica Nv	Alkyl linked quinolinyl modulators of RORγt
US9221804B2 (en)	2013-10-15	2015-12-29	Janssen Pharmaceutica Nv	Secondary alcohol quinolinyl modulators of RORγt
WO2015057626A1 (en)	2013-10-15	2015-04-23	Janssen Pharmaceutica Nv	QUINOLINYL MODULATORS OF RORyT
US10028503B2 (en)	2014-06-18	2018-07-24	Children's Hospital Medical Center	Platelet storage methods and compositions for same
LT3277842T (lt)	2015-08-17	2019-10-25	Kura Oncology Inc	Vėžio pacientų gydymo būdai farneziltransferazės inhibitoriais
WO2017184968A1 (en)	2016-04-22	2017-10-26	Kura Oncology, Inc.	Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
AR110031A1 (es)	2016-11-03	2019-02-13	Kura Oncology Inc	Métodos de tratamiento de pacientes con cáncer con inhibidores de farnesiltransferasa
US9956215B1 (en)	2017-02-21	2018-05-01	Kura Oncology, Inc.	Methods of treating cancer with farnesyltransferase inhibitors
KR102138904B1 (ko)	2017-02-21	2020-07-28	쿠라 온콜로지, 인크.	파르네실트랜스퍼라제 억제제를 사용하는 암 환자의 치료 방법
AU2018313738B2 (en)	2017-08-07	2024-07-04	Kura Oncology, Inc.	Methods of treating cancer with farnesyltransferase inhibitors
US10806730B2 (en)	2017-08-07	2020-10-20	Kura Oncology, Inc.	Methods of treating cancer with farnesyltransferase inhibitors
WO2019113269A1 (en)	2017-12-08	2019-06-13	Kura Oncology, Inc.	Methods of treating cancer patients with farnesyltransferase inhibitors
TW202031259A (zh)	2018-11-01	2020-09-01	美商庫拉腫瘤技術股份有限公司	以法尼基轉移酶(farnesyltransferase)抑制劑治療癌症之方法
US20220142983A1 (en)	2019-03-01	2022-05-12	Kura Oncology, Inc.	Methods of treating cancer with farnesyltransferase inhibitors
WO2020190604A1 (en)	2019-03-15	2020-09-24	Kura Oncology, Inc.	Methods of treating cancer patients with farnesyltransferase inhibitors
CN113795253A (zh)	2019-03-29	2021-12-14	库拉肿瘤学公司	用法呢基转移酶抑制剂治疗鳞状细胞癌的方法
WO2020205387A1 (en)	2019-04-01	2020-10-08	Kura Oncology, Inc.	Methods of treating cancer with farnesyltransferase inhibitors
WO2020223583A1 (en)	2019-05-02	2020-11-05	Kura Oncology, Inc.	Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6083917A (en) *	1990-04-18	2000-07-04	Board Of Regents, The University Of Texas System	Methods and compositions for the identification, characterization and inhibition of farnesyltransferase
US5141851A (en) *	1990-04-18	1992-08-25	Board Of Regents, The University Of Texas System	Isolated farnesyl protein transferase enzyme
US5602184A (en) *	1993-03-03	1997-02-11	The United States Of America As Represented By Department Of Health And Human Services	Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
TW349948B (en) *	1995-10-31	1999-01-11	Janssen Pharmaceutica Nv	Farnesyl transferase inhibiting 2-quinolone derivatives
DK0865440T3 (da) *	1995-12-08	2002-07-22	Janssen Pharmaceutica Nv	Farnesylproteinfransferaseinhiberende (imidazol-5-yl)-2-quinolinonderivater
EP0910385A4 (de) *	1996-04-15	1999-12-22	Univ Pennsylvania	Sensibilisierung von zellen zur strahlen- und chemotherapie
CA2260216A1 (en) *	1996-07-15	1998-01-22	Bristol-Myers Squibb Company	Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
TW591030B (en)	1997-03-10	2004-06-11	Janssen Pharmaceutica Nv	Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
CA2336624C (en)	1998-07-06	2008-10-21	Janssen Pharmaceutica N.V.	Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties
OA11833A (en) *	1999-02-11	2005-08-23	Pfizer Prod Inc	Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents.

1999
- 1999-06-30 CA CA002336624A patent/CA2336624C/en not_active Expired - Lifetime
- 1999-06-30 IL IL14072199A patent/IL140721A0/xx active IP Right Grant
- 1999-06-30 BR BR9911861-0A patent/BR9911861A/pt not_active Application Discontinuation
- 1999-06-30 DK DK99931229T patent/DK1094839T3/da active
- 1999-06-30 KR KR1020007014066A patent/KR100591603B1/ko not_active IP Right Cessation
- 1999-06-30 CN CNB998082678A patent/CN1152716C/zh not_active Expired - Lifetime
- 1999-06-30 SI SI9930332T patent/SI1094839T1/xx unknown
- 1999-06-30 WO PCT/EP1999/004545 patent/WO2000001411A1/en active IP Right Grant
- 1999-06-30 HU HU0103689A patent/HU229076B1/hu unknown
- 1999-06-30 ID IDW20010020A patent/ID26987A/id unknown
- 1999-06-30 SK SK1986-2000A patent/SK284723B6/sk not_active IP Right Cessation
- 1999-06-30 EE EEP200000794A patent/EE04582B1/xx unknown
- 1999-06-30 US US09/743,130 patent/US6545020B1/en not_active Expired - Lifetime
- 1999-06-30 AP APAP/P/2001/002057A patent/AP1599A/en active
- 1999-06-30 CZ CZ20004777A patent/CZ300968B6/cs not_active IP Right Cessation
- 1999-06-30 EA EA200100111A patent/EA003877B1/ru not_active IP Right Cessation
- 1999-06-30 AU AU47805/99A patent/AU762423B2/en not_active Expired
- 1999-06-30 PL PL99347979A patent/PL193464B1/pl unknown
- 1999-06-30 JP JP2000557857A patent/JP4530537B2/ja not_active Expired - Lifetime
- 1999-06-30 TR TR2000/03879T patent/TR200003879T2/xx unknown
- 1999-06-30 DE DE69907461T patent/DE69907461T2/de not_active Expired - Lifetime
- 1999-06-30 EP EP99931229A patent/EP1094839B1/de not_active Expired - Lifetime
- 1999-06-30 ES ES99931229T patent/ES2199579T3/es not_active Expired - Lifetime
- 1999-06-30 AT AT99931229T patent/ATE238811T1/de active
- 1999-06-30 PT PT99931229T patent/PT1094839E/pt unknown
- 1999-07-01 MY MYPI99002794A patent/MY126519A/en unknown
- 1999-07-05 TW TW088111346A patent/TW586937B/zh not_active IP Right Cessation
2000
- 2000-12-28 HR HR20000903A patent/HRP20000903A2/hr not_active Application Discontinuation
2001
- 2001-01-03 BG BG105108A patent/BG64941B1/bg unknown
- 2001-01-04 IL IL140721A patent/IL140721A/en not_active IP Right Cessation
- 2001-01-05 NO NO20010082A patent/NO328178B1/no not_active IP Right Cessation
- 2001-07-18 HK HK01105023A patent/HK1034451A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL193464B1 (pl)	2007-02-28
TW586937B (en)	2004-05-11
AU4780599A (en)	2000-01-24
AP2001002057A0 (en)	2001-03-31
EA003877B1 (ru)	2003-10-30
BG105108A (en)	2001-11-30
JP2002519389A (ja)	2002-07-02
CZ300968B6 (cs)	2009-09-30
KR20010052770A (ko)	2001-06-25
SK19862000A3 (sk)	2001-12-03
JP4530537B2 (ja)	2010-08-25
CN1311692A (zh)	2001-09-05
EP1094839A1 (de)	2001-05-02
US6545020B1 (en)	2003-04-08
BR9911861A (pt)	2001-03-20
WO2000001411A1 (en)	2000-01-13
PT1094839E (pt)	2003-09-30
SK284723B6 (sk)	2005-10-06
BG64941B1 (bg)	2006-10-31
AU762423B2 (en)	2003-06-26
CA2336624A1 (en)	2000-01-13
KR100591603B1 (ko)	2006-06-20
DE69907461D1 (de)	2003-06-05
EA200100111A1 (ru)	2001-06-25
NO20010082L (no)	2001-01-05
NO328178B1 (no)	2009-12-28
CA2336624C (en)	2008-10-21
PL347979A1 (en)	2002-05-06
CN1152716C (zh)	2004-06-09
EP1094839B1 (de)	2003-05-02
NO20010082D0 (no)	2001-01-05
IL140721A (en)	2008-11-26
TR200003879T2 (tr)	2007-01-22
AP1599A (en)	2006-04-27
EE200000794A (et)	2002-06-17
ID26987A (id)	2001-02-22
CZ20004777A3 (en)	2001-05-16
IL140721A0 (en)	2002-02-10
HUP0103689A3 (en)	2003-01-28
HU229076B1 (en)	2013-07-29
MY126519A (en)	2006-10-31
SI1094839T1 (en)	2003-12-31
DK1094839T3 (da)	2003-08-18
HK1034451A1 (en)	2001-10-26
ES2199579T3 (es)	2004-02-16
HUP0103689A2 (hu)	2002-02-28
EE04582B1 (et)	2006-02-15
HRP20000903A2 (en)	2001-12-31
DE69907461T2 (de)	2004-02-19

Publication	Publication Date	Title
ATE238811T1 (de)	2003-05-15	Inhibitoren von farnesylprotein-transferase mit radiosensibilisierenden eigenschaften
EE9800262A (et)	1999-02-15	Farnesüül-proteiini transferaasi inhibiitorid
EE9800408A (et)	1999-06-15	Proteiinfarnesüültransferaasi inhibiitorid
LTPA2014028I1 (lt)	2014-08-25	Pakeistieji 3-cianochinolinai kaip proteintirozinkinazės inhibitoriai
NO996571D0 (no)	1999-12-30	Inhibitorer for farnesyl-protein-transferase
EE9700314A (et)	1998-06-15	Farnesüül-proteiini transferaasi inhibiitorid
FI952010A0 (fi)	1995-04-27	Farnesyyliproteiinitransferaasin estäjät
ATE293622T1 (de)	2005-05-15	Farnesyl protein transferase inhibitoren
ATE546139T1 (de)	2012-03-15	Isoprentransferase proteine inhibitoren
ID24289A (id)	2000-07-13	Benzotiazol inhibitor-inhibitor protein terosin kinase
ID30460A (id)	2001-12-06	Inhibitor-inhibitor protein siklik tirosin kinase
AU2001246477A1 (en)	2001-09-12	Farnesyl protein transferase inhibitor combinations with platinum compounds
DE69825589D1 (de)	2004-09-16	Benzpyrido cycloheptan derivate mit farnesyl protein transferase inhibierender wirkung
NO20012961D0 (no)	2001-06-15	Trisykliske farnesylproteintransferase-inhibitorer
DE69614075D1 (de)	2001-08-30	Inhibitoren von Mehrfachresistenzen
ATE295417T1 (de)	2005-05-15	Angiostatin-bindendes protein
ATE214367T1 (de)	2002-03-15	Farnesyl transferase inhibitoren
ATE371655T1 (de)	2007-09-15	Farnesyl-protein-transferaseinhibitoren
NO20013699L (no)	2001-09-26	Meg-4-protein
NO20022923L (no)	2002-06-18	Inhibitorer av farnesyl-protein-transferase
BR1101059A (pt)	2006-09-26	inibidores de agregação de plaquetas
DK1124843T3 (da)	2004-08-09	Lavallergene proteinvarianter

Legal Events

Date	Code	Title	Description
2003-12-15	UEP	Publication of translation of european patent specification	Ref document number: 1094839 Country of ref document: EP

Date

Code

Title

Description

2003-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1094839

Country of ref document: EP